Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.16% is 244% above its 5-year average of 0.05%, near the low end of its 5-year range (0.00%–78.21%).
As of the fiscal period ended Tuesday, June 30, 2026. 9.59% below its 12-month average of 0.17%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.16%.
DEBT TO ASSETS RATIO
0.16%
DEBT TO ASSETS RATIO AVG TTM
0.17%
DEBT TO ASSETS RATIO AVG 3Y
0.08%
DEBT TO ASSETS RATIO AVG 5Y
0.05%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-9.59%
CURRENT VS 3Y AVG
+98.90%
CURRENT VS 5Y AVG
+243.56%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+75.59%
vs the sector median at left
Dogwood Therapeutics, Inc.
Market Cap
$51.12M
Debt to Assets Ratio
0.16%
TTM Avg
0.17%
3Y Avg
0.08%
5Y Avg
0.05%
Market Cap
$51.19M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$50.27M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.99M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$52.60M
Debt to Assets Ratio
0.17%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | $51.12M | 0.16% | 0.17% | 0.08% | 0.05% |
| Tenax Therapeutics, Inc. (TENX)vs › | $51.19M | 0.00% | N/A | N/A | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | 0.14% | N/A | N/A | N/A |
| ImageneBio Inc (IMA)vs › | $51.88M | 0.01% | N/A | N/A | N/A |
| biote Corp. (BTMD)vs › | $50.28M | 1.26% | N/A | N/A | N/A |
| Envoy Medical, Inc. (COCH)vs › | $50.27M | 0.03% | N/A | N/A | N/A |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.99M | 0.00% | N/A | N/A | N/A |
| INmune Bio, Inc. (INMB)vs › | $49.71M | 0.05% | N/A | N/A | N/A |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $52.60M | 0.17% | N/A | N/A | N/A |
| Clene Inc. (CLNN)vs › | $49.45M | 0.97% | N/A | N/A | N/A |
Debt/Assets
0.2%
Debt/Equity
0.00
Current Ratio
3.89
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.16% |
| 2026-03-31 | 0.15% |
| 2025-12-31 | 0.18% |
| 2025-09-30 | 0.19% |
| 2025-06-30 | 0.19% |
| 2025-03-31 | 78.21% |
| 2024-12-31 | 16.53% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 528.51% |
| 2020-06-30 | 431.14% |
| 2019-12-31 | 1151.49% |
